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This study was carried out to investigate the effects of Newcastle disease 
virus (NDV) strain V4-UPM in eliminating breast cancer cells through the 
apoptosis machinery process and the potential use of the virus as an agent 
for breast cancer therapy. Oncolytic effects of V4-UPM NDV on 4T1, a 
mouse mammary cancer cell line was investigated via in-vitro and in-vivo 
assays, and three of the apoptosis characteristic were evaluated through 
various methods. Propagation of V4-UPM NDV was conducted in the 
allantoic fluid of 10 day old embryonated chicken eggs after 5 to 7 days 
incubation. The fluid was harvested, purified, and the haemagglutination 
(HA) test was carried out to determine the HA titre of the virus.  The HA titre 
obtained from purified V4-UPM NDV was 131 072 or 217. Cytotoxic effects of 
V4-UPM NDV on 4T1 cell line were first carried out using microculture 
tetrazolium (MTT) assay to determine the amount required to kill 50% of 
cancer cells. It was observed that 32 768 or 215 HA unit was required to kill 
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50% of the 4T1 cells.  Further studies were done by observing the 
morphological changes in treated cells under scanning electron microscope 
(SEM). The cells treated with V4-UPM NDV showed apoptotic characteristics 
such as shrinkage and reduction in cell size, cell indention, membrane 
blebbing and dispersion of cells, compared with oval to round, smooth 
surface of untreated 4T1 cells. By using confocal microscope, localization of 
tumor suppressor gene p53 and mitochondria activity in treated cells were 
evaluated to identify the involvement during the process of apoptosis. 
Positive localization of p53 in the nucleus of untreated cells was observed 
after labeling with anti-p53 monoclonal antibody and the localization of p53 
outside the nucleus was clearly seen after treatment. V4-UPM NDV is 
suggested to enhance the function of p53 to cause 4T1 cells to commit 
suicide. The mitochondrial activity was investigated by using mitotracker red 
staining and low involvement of mitochondria activity in cancer cells was 
observed in untreated cells. Greenish fluorescence was observed in treated 
cells showing higher involvement of mitochondrial activity during apoptosis.  
 
Further investigations were carried out based on the in-vitro studies as a 
preclinical trial on an animal breast cancer model (in-vivo) to evaluate the 
effects of V4-UPM NDV on cancer tissue. Female inbred Balb/c mice were 
used as an animal model and induction of cancer was done through 
inoculation of 4T1 cells into subcutaneous mammary fat pad. After 10 to 14 
days, the tumor growth was observed in all induced mice. The statistical 
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analysis of tumor development showed a significant difference (p ≤ 0.05) of 
tumor volume between control cancer cells and cancer cells treated with V4-
UPM NDV. However, no significant changes were observed in body weight 
and tumor mass.  Cell proliferation was significantly reduced as shown by 
the measurement of apoptotic:mitotic cell via lesion score counted under 
light microscope.  Confirmation of apoptotic cells by specific labeling of DNA 
fragment with TdT mediated dUTP nick end labeling (TUNEL) assay showed 
a higher apoptotic percentage counted in cancer cells treated with V4-UPM 
NDV as compared with cancer control cells. Ultrastructural features of 
treated tissue were viewed under energy filtered transmission electron 
microscope (EFTEM) to confirm that cell death due to V4-UPM NDV is via 
apoptotic pathway. Cells were observed to be tightly connected with other 
cells, with clear boundaries and with the normal structure of organelles in 
cancer control cells. The distinct ultrastructural changes prominently seen in 
4T1 cells treated with V4-UPM NDV were the apoptotic characteristics, such 
as, cell shrinkage and resulting spaces in between cells, membrane 
blebbing, shrunken nucleus and also the presence of numerous numbers of 
mitochondria and endoplasmic reticulum (ER). From these findings, it was 
confirmed that the mode of cell death induced by V4-UPM NDV, to eliminate 
the cancer cells is by apoptosis. This suggested that V4-UPM NDV is a 
potential agent for breast cancer treatment. 
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Kajian ini dilakukan untuk menyelidik kesan virus penyakit Newcastle (NDV) 
strain V4-UPM dalam menghapuskan sel kanser payu dara melalui proses 
apoptosis dan juga potensi virus ini bertindak sebagai agen untuk terapi 
kanser payudara. Kesan onkolitik NDV V4-UPM pada 4T1, sel kanser 
payudara mencit diselidik secara in-vitro dan in-vivo, dan tiga ciri apoptosis 
disiasat melalui pelbagai kaedah. V4-UPM NDV di propagasi dalam cecair 
alantoik telur ayam berembrio berusia 10 hari yang telah dieramkan selama 
5 hingga 7 hari. Cecair alantoik tersebut dikumpulkan, dipurifikasi dan ujian 
hemagglutinasi (HA) dilakukan untuk menentukan HA titer virus ini. HA titer 
yang diperolehi daripada virus V4-UPM NDV yang telah ditulenkan ialah 131 
072 atau 217 . Kesan sitotoksik V4-UPM NDV pada sel 4T1 telah dilakukan 
kali pertama dengan menggunakan ujian ‘microculture tetrazolium’ (MTT) 
untuk menentukan jumlah yang diperlukan bagi membunuh 50% sel kanser. 
Ianya didapati sebanyak 32 768 atau 215 HA unit diperlukan untuk 
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membunuh 50% sel 4T1. Kajian seterusnya dilakukan dengan melihat 
perubahan morfologi dalam sel yang dirawat dengan menggunakan 
mikroskop pengimbas elektron (SEM). Sel yang dirawat dengan V4-UPM 
NDV menunjukkan ciri-ciri apoptosis seperti sel mengecut and saiznya 
mengecil, sel melekuk ke dalam, membran menggelembung dan sel pecah 
dibandingkan dengan sel 4T1 yang tidak dirawat, yang menunjukkan sel 
yang membulat serta permukaan membran yang licin. Dengan penggunaan 
mikroskop konfokal, lokasi gen perencat tumor, p53 dan aktiviti mitokondria 
di kaji untuk mengenalpasti penglibatan semasa apoptosis berlaku. Lokasi 
p53 terletak di dalam nukleus pada sel 4T1 yang tidak dirawat setelah 
dilabel menggunakan antibodi monoklonal anti p53, dan perubahan lokasi 
p53 diluar nukleus dilihat dengan jelas selepas dirawat. V4-UPM NDV 
dijangka meningkatkan fungsi p53 untuk menyebabkan sel 4T1 mati. Aktiviti 
mitokondria dikaji dengan menggunakan perwarnaan ‘mitotracker red’ dan 
aktiviti mitokondria yang rendah dalam sel kanser dilihat pada sel yang tidak 
dirawat. Warna hijau floures diperolehi dalam sel yang dirawat menunjukkan 
penglibatan aktiviti mitokondria yang tinggi semasa apoptosis berlaku.  
 
Kajian seterusnya dilakukan berdasarkan hasil kajian in-vitro sebagai 
percubaan pra klinikal menggunakan model haiwan kanser payudara (in-
vivo) untuk melihat kesan V4- UPM NDV pada tisu kanser. Balb/c mencit 
betina yang sebaka digunakan sebagai model haiwan dan kanser induksi 
dilakukan dengan menginokulasi sel 4T1 ke dalam lemak di bawah lapisan 
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mamari. Selepas 10 hingga 14 hari didapati semua mencit yang di induksi 
menunjukan pertumbuhan tumor. Statistikal analisis pertumbuhan tumor 
menunjukan perbezaan yang signifikan (p ≤ 0.05) isipadu tumor di antara sel 
kanser kawalan dan sel kanser yang dirawat dengan V4-UPM NDV. Walau 
bagaimanpun, tiada perubahan yang signifikan diperolehi ke atas berat 
badan dan jisim tumor. Proliferasi sel menurun dengan signifikan seperti 
yang ditunjukkan selepas mengukur sel apoptotik:mitotik melalui kaedah 
skor lesi yang di kira di bawah mikroskop cahaya. Pengenalpastian sel 
apoptotik menggunakan label spesifik pecahan DNA iaitu ujian ‘TdT 
mediated dUTP nick end labeling’ (TUNEL) menunjukkan peratusan 
apoptotik yang tinggi pada kanser sel yang dirawat dengan V4-UPM NDV 
dibandingkan dengan kanser sel kawalan. Bentuk ultrastruktur tisu yang 
dirawat di kaji menggunakan mikroskop elektron pancaran penuras tenaga 
(EFTEM) untuk menentukan bahawa kematian sel disebabkan oleh V4-UPM 
NDV adalah melalui mekanisma apoptosis.  Sel didapati bersusun dengan 
rapat diantara satu sama lain dengan sempadan yang jelas serta struktur 
normal organel pada kanser sel kawalan. Perubahan ultrastruktur yang jelas 
dan ketara dilihat pada sel 4T1 yang dirawat dengan V4-UPM NDV 
menunjukan ciri-ciri apoptosis, seperti sel mengecil dan menyebabkan 
kehadiran ruang diantara sel, membran menggelembung, nukleus mengecut 
dan juga mitokondria dan endoplasmik retikulum yang banyak.  Daripada 
penemuan ini, didapati cara sel mati yang diransang oleh V4-UPM NDV 
untuk menghapuskan sel kanser adalah melalui apoptosis. Ini menunjukan 
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V4-UPM NDV adalah agen yang berpotensi sebagai rawatan kanser 
payudara.  
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 CHAPTER 1 
 
INTRODUCTION 
 
‘Cancer’ is a well-known word among people in the world and it often strikes 
fear in people. Indeed, cancer is considered to be one of the major causes of 
death around the world including Malaysia. Globocan (2000) reported that 
an estimated 5.4 million people all over the world are afflicted with cancer 
and 51% of those affected are in developing countries.  
 
The incidence of various kinds of cancer in Malaysia has been estimated to 
be around 30,000 annually and constitutes 10.3% of medically certified 
death, which is the fourth leading cause of death (Lim et al., 1993; Gerard 
2002). The most predominant cancer affecting males in Malaysia are 
cancers of the lung, nasopharynx, mouth, stomach and liver, while the most 
prevalent cancers among females are cancers of the breast, cervix, lung and 
stomach (Gerard, 2002).  
 
Breast cancer is the first leading cause of death among women. It is the 
most frequently diagnosed in the western world with approximately 180,000 
new cases identified annually in the United States of America (USA) alone 
and currently the second leading cause of cancer-related mortality in women 
in USA (McPherson et al., 2000). The estimated breast cancer incidence in 
 1
